Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: A4ICU0
Term | Name | Level | Count |
---|---|---|---|
GO:0002943 | tRNA dihydrouridine synthesis | 7 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008033 | tRNA processing | 8 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 11 |
GO:0017150 | tRNA dihydrouridine synthase activity | 5 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0050660 | flavin adenine dinucleotide binding | 4 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0106413 | dihydrouridine synthase activity | 4 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 11 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 268 | 272 | PF00656 | 0.537 |
CLV_NRD_NRD_1 | 298 | 300 | PF00675 | 0.273 |
CLV_NRD_NRD_1 | 408 | 410 | PF00675 | 0.588 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.356 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.265 |
CLV_PCSK_KEX2_1 | 410 | 412 | PF00082 | 0.632 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.364 |
CLV_PCSK_PC1ET2_1 | 154 | 156 | PF00082 | 0.356 |
CLV_PCSK_PC1ET2_1 | 182 | 184 | PF00082 | 0.301 |
CLV_PCSK_PC1ET2_1 | 410 | 412 | PF00082 | 0.632 |
CLV_PCSK_PC1ET2_1 | 78 | 80 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.313 |
CLV_PCSK_SKI1_1 | 204 | 208 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 275 | 279 | PF00082 | 0.367 |
CLV_PCSK_SKI1_1 | 288 | 292 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 330 | 334 | PF00082 | 0.371 |
CLV_PCSK_SKI1_1 | 340 | 344 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 358 | 362 | PF00082 | 0.506 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.469 |
CLV_Separin_Metazoa | 244 | 248 | PF03568 | 0.556 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.453 |
DEG_SCF_FBW7_2 | 60 | 66 | PF00400 | 0.521 |
DOC_CKS1_1 | 211 | 216 | PF01111 | 0.529 |
DOC_CKS1_1 | 60 | 65 | PF01111 | 0.526 |
DOC_CKS1_1 | 83 | 88 | PF01111 | 0.394 |
DOC_CYCLIN_RxL_1 | 327 | 336 | PF00134 | 0.415 |
DOC_CYCLIN_yCln2_LP_2 | 83 | 89 | PF00134 | 0.443 |
DOC_MAPK_gen_1 | 179 | 188 | PF00069 | 0.453 |
DOC_MAPK_gen_1 | 299 | 306 | PF00069 | 0.403 |
DOC_MAPK_MEF2A_6 | 100 | 108 | PF00069 | 0.512 |
DOC_MAPK_MEF2A_6 | 11 | 20 | PF00069 | 0.324 |
DOC_MAPK_NFAT4_5 | 105 | 113 | PF00069 | 0.537 |
DOC_PP1_RVXF_1 | 328 | 335 | PF00149 | 0.473 |
DOC_USP7_MATH_1 | 169 | 173 | PF00917 | 0.540 |
DOC_USP7_MATH_1 | 310 | 314 | PF00917 | 0.605 |
DOC_USP7_MATH_1 | 416 | 420 | PF00917 | 0.643 |
DOC_USP7_UBL2_3 | 74 | 78 | PF12436 | 0.412 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.491 |
DOC_WW_Pin1_4 | 210 | 215 | PF00397 | 0.509 |
DOC_WW_Pin1_4 | 225 | 230 | PF00397 | 0.400 |
DOC_WW_Pin1_4 | 59 | 64 | PF00397 | 0.536 |
DOC_WW_Pin1_4 | 82 | 87 | PF00397 | 0.391 |
LIG_14-3-3_CanoR_1 | 183 | 189 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 338 | 343 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 382 | 386 | PF00244 | 0.418 |
LIG_AP2alpha_2 | 71 | 73 | PF02296 | 0.484 |
LIG_APCC_ABBA_1 | 360 | 365 | PF00400 | 0.498 |
LIG_BRCT_BRCA1_1 | 21 | 25 | PF00533 | 0.471 |
LIG_EH1_1 | 395 | 403 | PF00400 | 0.397 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.459 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.406 |
LIG_FHA_1 | 395 | 401 | PF00498 | 0.604 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.437 |
LIG_FHA_2 | 382 | 388 | PF00498 | 0.493 |
LIG_GBD_Chelix_1 | 184 | 192 | PF00786 | 0.337 |
LIG_LIR_Gen_1 | 341 | 350 | PF02991 | 0.416 |
LIG_LIR_Gen_1 | 376 | 385 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 252 | 258 | PF02991 | 0.533 |
LIG_LIR_Nem_3 | 331 | 337 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 341 | 346 | PF02991 | 0.383 |
LIG_LIR_Nem_3 | 351 | 357 | PF02991 | 0.177 |
LIG_LIR_Nem_3 | 376 | 381 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 66 | 70 | PF02991 | 0.341 |
LIG_LYPXL_yS_3 | 57 | 60 | PF13949 | 0.506 |
LIG_PCNA_PIPBox_1 | 326 | 335 | PF02747 | 0.453 |
LIG_PTB_Apo_2 | 342 | 349 | PF02174 | 0.471 |
LIG_PTB_Phospho_1 | 342 | 348 | PF10480 | 0.475 |
LIG_REV1ctd_RIR_1 | 378 | 386 | PF16727 | 0.420 |
LIG_SH2_CRK | 339 | 343 | PF00017 | 0.385 |
LIG_SH2_NCK_1 | 239 | 243 | PF00017 | 0.462 |
LIG_SH2_STAP1 | 239 | 243 | PF00017 | 0.462 |
LIG_SH2_STAP1 | 324 | 328 | PF00017 | 0.475 |
LIG_SH2_STAP1 | 335 | 339 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 374 | 378 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.432 |
LIG_SH3_3 | 109 | 115 | PF00018 | 0.477 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.463 |
LIG_SH3_3 | 211 | 217 | PF00018 | 0.521 |
LIG_SH3_3 | 52 | 58 | PF00018 | 0.513 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.485 |
LIG_SUMO_SIM_anti_2 | 397 | 403 | PF11976 | 0.500 |
LIG_SUMO_SIM_par_1 | 79 | 85 | PF11976 | 0.428 |
LIG_TRAF2_1 | 384 | 387 | PF00917 | 0.394 |
LIG_TRAF2_1 | 418 | 421 | PF00917 | 0.636 |
LIG_TYR_ITIM | 337 | 342 | PF00017 | 0.470 |
LIG_TYR_ITIM | 55 | 60 | PF00017 | 0.510 |
MOD_CDK_SPxxK_3 | 19 | 26 | PF00069 | 0.478 |
MOD_CDK_SPxxK_3 | 225 | 232 | PF00069 | 0.537 |
MOD_CK1_1 | 187 | 193 | PF00069 | 0.480 |
MOD_CK1_1 | 265 | 271 | PF00069 | 0.462 |
MOD_CK1_1 | 405 | 411 | PF00069 | 0.417 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.473 |
MOD_CK2_1 | 381 | 387 | PF00069 | 0.420 |
MOD_Cter_Amidation | 180 | 183 | PF01082 | 0.294 |
MOD_DYRK1A_RPxSP_1 | 19 | 23 | PF00069 | 0.485 |
MOD_GlcNHglycan | 307 | 310 | PF01048 | 0.340 |
MOD_GlcNHglycan | 403 | 407 | PF01048 | 0.485 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.454 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.584 |
MOD_GSK3_1 | 390 | 397 | PF00069 | 0.525 |
MOD_GSK3_1 | 412 | 419 | PF00069 | 0.632 |
MOD_GSK3_1 | 431 | 438 | PF00069 | 0.669 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.445 |
MOD_N-GLC_1 | 262 | 267 | PF02516 | 0.251 |
MOD_NEK2_1 | 262 | 267 | PF00069 | 0.465 |
MOD_NEK2_1 | 304 | 309 | PF00069 | 0.492 |
MOD_NEK2_1 | 333 | 338 | PF00069 | 0.447 |
MOD_NEK2_1 | 390 | 395 | PF00069 | 0.473 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.510 |
MOD_PK_1 | 140 | 146 | PF00069 | 0.451 |
MOD_PKA_1 | 140 | 146 | PF00069 | 0.451 |
MOD_PKA_1 | 299 | 305 | PF00069 | 0.473 |
MOD_PKA_2 | 304 | 310 | PF00069 | 0.465 |
MOD_PKA_2 | 381 | 387 | PF00069 | 0.468 |
MOD_Plk_1 | 196 | 202 | PF00069 | 0.537 |
MOD_Plk_1 | 3 | 9 | PF00069 | 0.487 |
MOD_Plk_2-3 | 370 | 376 | PF00069 | 0.490 |
MOD_Plk_2-3 | 66 | 72 | PF00069 | 0.423 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.504 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.433 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.489 |
MOD_ProDKin_1 | 210 | 216 | PF00069 | 0.509 |
MOD_ProDKin_1 | 225 | 231 | PF00069 | 0.400 |
MOD_ProDKin_1 | 59 | 65 | PF00069 | 0.529 |
MOD_ProDKin_1 | 82 | 88 | PF00069 | 0.395 |
MOD_SUMO_for_1 | 1 | 4 | PF00179 | 0.473 |
MOD_SUMO_rev_2 | 268 | 277 | PF00179 | 0.512 |
MOD_SUMO_rev_2 | 420 | 430 | PF00179 | 0.639 |
TRG_DiLeu_BaEn_1 | 256 | 261 | PF01217 | 0.431 |
TRG_ENDOCYTIC_2 | 339 | 342 | PF00928 | 0.393 |
TRG_ENDOCYTIC_2 | 378 | 381 | PF00928 | 0.381 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.506 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.418 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6Z1 | Leptomonas seymouri | 66% | 100% |
A0A0S4JLG1 | Bodo saltans | 38% | 87% |
A0A0S4JUA9 | Bodo saltans | 24% | 96% |
A0A1X0P8K8 | Trypanosomatidae | 44% | 100% |
A0A3Q8IJ00 | Leishmania donovani | 100% | 100% |
A0A3Q8IN46 | Leishmania donovani | 23% | 89% |
A0A3R7KZP3 | Trypanosoma rangeli | 27% | 100% |
A0A422P287 | Trypanosoma rangeli | 48% | 100% |
A4HAN2 | Leishmania braziliensis | 22% | 100% |
A4HNQ5 | Leishmania braziliensis | 79% | 100% |
A4I9S4 | Leishmania infantum | 23% | 100% |
D0A2L3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9ASG4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
E9B4T5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
O74553 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 25% | 100% |
O74731 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 92% |
P37567 | Bacillus subtilis (strain 168) | 25% | 100% |
P53720 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 100% |
Q4Q231 | Leishmania major | 92% | 100% |
Q4Q391 | Leishmania major | 25% | 89% |
Q8CU07 | Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) | 26% | 100% |
Q8PP72 | Xanthomonas axonopodis pv. citri (strain 306) | 27% | 100% |
Q8XYX1 | Ralstonia solanacearum (strain GMI1000) | 28% | 100% |
Q9D7B1 | Mus musculus | 28% | 89% |
Q9NX74 | Homo sapiens | 28% | 89% |
V5DJT2 | Trypanosoma cruzi | 27% | 100% |
V5DRQ6 | Trypanosoma cruzi | 49% | 100% |